REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,343,282 | +24.1% | 698,818 | +19.9% | 0.00% | +100.0% |
| Q2 2023 | $15,587,547 | -39.9% | 582,712 | -51.3% | 0.00% | 0.0% |
| Q1 2023 | $25,934,428 | +153.3% | 1,197,342 | +178.6% | 0.00% | 0.0% |
| Q4 2022 | $10,237,050 | +20.0% | 429,767 | -0.7% | 0.00% | 0.0% |
| Q3 2022 | $8,534,000 | +567.8% | 432,750 | +560.2% | 0.00% | – |
| Q2 2022 | $1,278,000 | -98.3% | 65,553 | -97.7% | 0.00% | -100.0% |
| Q1 2022 | $73,138,000 | -52.4% | 2,867,020 | -53.0% | 0.01% | -45.5% |
| Q4 2021 | $153,580,000 | -28.4% | 6,101,724 | -21.8% | 0.01% | -35.3% |
| Q3 2021 | $214,521,000 | -29.1% | 7,797,884 | -18.2% | 0.02% | -29.2% |
| Q2 2021 | $302,618,000 | -39.1% | 9,534,259 | -12.0% | 0.02% | -42.9% |
| Q1 2021 | $496,984,000 | +34.4% | 10,832,245 | +16.0% | 0.04% | +27.3% |
| Q4 2020 | $369,750,000 | +7.4% | 9,339,485 | -5.6% | 0.03% | -5.7% |
| Q3 2020 | $344,135,000 | +38.8% | 9,888,961 | +25.1% | 0.04% | +29.6% |
| Q2 2020 | $247,946,000 | +72.4% | 7,903,725 | +18.6% | 0.03% | +35.0% |
| Q1 2020 | $143,824,000 | – | 6,664,063 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |